Primary |
Hypertension |
83.3% |
Product Used For Unknown Indication |
8.3% |
Coronary Artery Disease |
4.2% |
Prophylaxis |
4.2% |
|
Angioedema |
26.9% |
Lip Oedema |
7.7% |
Mental Impairment |
7.7% |
Renal Failure |
7.7% |
Dysarthria |
3.8% |
Head Discomfort |
3.8% |
Memory Impairment |
3.8% |
Pain |
3.8% |
Pancreatitis |
3.8% |
Peripheral Coldness |
3.8% |
Pharyngeal Oedema |
3.8% |
Pruritus |
3.8% |
Renal Failure Acute |
3.8% |
Swelling Face |
3.8% |
Treatment Noncompliance |
3.8% |
Vomiting |
3.8% |
Weight Increased |
3.8% |
|
Secondary |
Hypertension |
44.3% |
Product Used For Unknown Indication |
15.7% |
Drug Use For Unknown Indication |
12.9% |
Coronary Artery Disease |
5.7% |
Depression |
5.7% |
Blood Pressure High |
4.3% |
Acid Reflux (Esophageal) |
1.4% |
Arthritic Pains |
1.4% |
Arthritis |
1.4% |
Benign Prostatic Hyperplasia |
1.4% |
Crohn's Disease |
1.4% |
Diabetes Mellitus |
1.4% |
Gastrooesophageal Reflux Disease |
1.4% |
Hyperthyroidism |
1.4% |
|
Renal Failure |
29.4% |
Sick Sinus Syndrome |
11.8% |
Weight Decreased |
11.8% |
Agranulocytosis |
5.9% |
Allergic Myocarditis |
5.9% |
Angioneurotic Oedema |
5.9% |
Completed Suicide |
5.9% |
Heart Transplant |
5.9% |
Nausea |
5.9% |
Orthostatic Hypotension |
5.9% |
Rash Pruritic |
5.9% |
|
Concomitant |
Product Used For Unknown Indication |
24.2% |
Hypertension |
15.7% |
Drug Use For Unknown Indication |
7.2% |
Diabetes Mellitus |
6.3% |
Cardiac Failure Congestive |
4.8% |
Blood Cholesterol Increased |
4.3% |
Hormone Replacement Therapy |
4.3% |
Depression |
3.8% |
Rheumatoid Arthritis |
3.4% |
Diffuse Large B-cell Lymphoma |
3.1% |
Type 2 Diabetes Mellitus |
2.9% |
Blood Pressure |
2.6% |
Chronic Obstructive Pulmonary Disease |
2.6% |
Gastrooesophageal Reflux Disease |
2.4% |
Squamous Cell Carcinoma Of Head And Neck |
2.4% |
Cardiac Disorder |
2.2% |
Psoriasis |
2.2% |
Pain |
2.0% |
Anxiety |
1.9% |
Blood Cholesterol |
1.9% |
|
Renal Failure |
10.5% |
Vomiting |
9.3% |
Breast Cancer Female |
7.0% |
Upper Gastrointestinal Haemorrhage |
7.0% |
Visual Impairment |
7.0% |
Rash |
5.8% |
Drug Ineffective |
4.7% |
International Normalised Ratio Increased |
4.7% |
Myocardial Infarction |
4.7% |
Thrombocytopenia |
4.7% |
Cardiac Failure Congestive |
3.5% |
Injection Site Pain |
3.5% |
Myalgia |
3.5% |
Nausea |
3.5% |
Squamous Cell Carcinoma |
3.5% |
Subdural Haematoma |
3.5% |
Syncope |
3.5% |
Weight Decreased |
3.5% |
Weight Increased |
3.5% |
Wheezing |
3.5% |
|